Sangmin Kim

Samsung Medical Center

Papers

1

Total Citations

114

H-Index

1

About

Dr. Sangmin Kim is a pioneering surgeon whose research has fundamentally reshaped the landscape of thyroid cancer surgery, particularly through the comparative evaluation of robotic, endoscopic, and open techniques. His landmark 2011 study, "Is Robotic Surgery Superior to Endoscopic and Open Surgeries in Thyroid Cancer?"—cited over 114 times—stands as a critical benchmark in the field, systematically analyzing the clinical outcomes, cosmetic benefits, and safety profiles of these competing approaches. Dr. Kim’s work has been instrumental in defining the indications and limitations of minimally invasive thyroid surgery, especially the bilateral axillo-breast approach, which he helped validate as a viable option offering superior aesthetic results without compromising oncologic integrity. By providing rigorous evidence on surgical efficacy, he has guided countless surgeons in selecting optimal techniques for their patients. His contributions have not only advanced surgical precision but also improved patient quality of life, cementing his reputation as a key thought leader in the evolution of thyroid cancer management. For students and researchers, Dr. Kim’s scholarship exemplifies how comparative effectiveness research can drive meaningful clinical innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
114
Total Citations
114
Avg Citations/Paper
🏆 Most Cited Paper
Is Robotic Surgery Superior to Endoscopic and Open Surgeries in Thyroid Cancer?
114 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Samsung Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago